Latest ondansetron Stories
DALLAS, January 22, 2015 /PRNewswire/ -- The Global Anxiety Disorders Market 2015-2019 research report, now available with ReportsnReports.com, says that in addition to
BUDAPEST, Hungary and DUBLIN, Jan. 20, 2015 /PRNewswire/ -- Gedeon Richter Plc.
MILAN, December 19, 2014 /PRNewswire/ -- - First New Chemical Entity (NCE) in 10 years to receive a positive opinion from CHMP for the treatment
MOUNTAIN VIEW, Calif. and BARCELONA, Spain, Dec. 11, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer Internacional, S.A.
SAN DIEGO, Oct. 30, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S.
LUGANO, Switzerland, October 23, 2014 /PRNewswire/ -- ~ At a dose of 20 mug/kg, Palonosetron, administered as a singledose, is as effective as ondansetron 0.15 mg/kg given
SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc.
ADASUVE Initial Product Inventory Stocking Completed MOUNTAIN VIEW, Calif., Oct. 9, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on the U.S.
CAMBRIDGE, England, October 7, 2014 /PRNewswire/ -- Acacia Pharma announces positive Phase 3 results with APD421 for the management of post-operative nausea & vomiting
- totally perplexed and mixed up.